UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007719
Receipt number R000008612
Scientific Title Clinical study on the analgesic efficacy of a 4-week combination of NSAIDs patch and celecoxib in patients with Knee Osteoarthritis who responded poorly to monotherapy with NSAIDs patch (A randomized, open-label, parallel-group, controlled study compared to home based exercise therapy)
Date of disclosure of the study information 2012/04/11
Last modified on 2022/10/19 14:19:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study on the analgesic efficacy of a 4-week combination of NSAIDs patch and celecoxib in patients with Knee Osteoarthritis who responded poorly to monotherapy with NSAIDs patch (A randomized, open-label, parallel-group, controlled study compared to home based exercise therapy)

Acronym

Clinical study on the analgesic efficacy of NSAIDs patch and celecoxib in patients with Knee Osteoarthritis who responded poorly to monotherapy with NSAIDs patch

Scientific Title

Clinical study on the analgesic efficacy of a 4-week combination of NSAIDs patch and celecoxib in patients with Knee Osteoarthritis who responded poorly to monotherapy with NSAIDs patch (A randomized, open-label, parallel-group, controlled study compared to home based exercise therapy)

Scientific Title:Acronym

Clinical study on the analgesic efficacy of NSAIDs patch and celecoxib in patients with Knee Osteoarthritis who responded poorly to monotherapy with NSAIDs patch

Region

Japan


Condition

Condition

Knee Osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to perform an exploratory examination of the analgesic efficacy and safety of the combination of NSAIDs patch and celecoxib in patients with Knee Osteoarthritis who responded poorly to monotherapy with NSAIDs patch, in comparison with the combination of NSAIDs patch and home based exercise therapy, which is recommended in the treatment guidelines for osteoarthritis of the knee, in a 4-week randomized, open-label, parallel-group, controlled study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase IV


Assessment

Primary outcomes

Average change in pain VAS at the final assessment from the baseline.

Key secondary outcomes

(1) General improvement rate evaluated by doctor at final assessment (assessed in five stages: 1. Marked improvement, 2. Moderate improvement, 3. Slight improvement, 4. Unchanged, 5. Worse).
(2) Comparison of improvement rates (changes from baseline) of Japanese Knee Osteoarthritis Measure score at final assessment.
(3) Average change in pain VAS according to patient diary (Comparison between baseline and day 1, day 3, day 7, day 14, and day 28 of celecoxib treatment or exercise treatment).
(4) Health and sleep patterns according to patient diary (Comparison between baseline and day 1, day 3, day 7, day 14, and day 28 of celecoxib treatment or exercise treatment).
(5) Compliance with exercise treatment according to patient questionnaire on treatment at final assessment.
(6) Treatment compliance according to patient questionnaire on treatment at final assessment.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Behavior,custom

Interventions/Control_1

A fixed daily dose of Celecoxib (200mg/day in 2 divided doses) will be administered orally for 4 weeks.

Interventions/Control_2

home based exercise therapy for 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Patients diagnosed with osteoarthritis of the knee by the doctor (irrelevant of gender)
(2) Age range from 30 to 90 years.
(3) Patients responding poorly to NSAID patch alone for more than 2 weeks (visit 2) (VAS value &#8805; 30 mm).
(4) Patients graded between 1 to 4 according to the Kellgren and Lawrence Classification.
(5) Patients willing to sign written consent regarding participation in this study.

Key exclusion criteria

(1) Patients diagnosed with rheumatoid arthritis, inflammatory arthritis, or gout, or those with injuries at evaluated region.
(2) Patients who have received surgical or drug treatment for the evaluated knee during the study period.
(3) Patients with diseases requiring continuous or intermittent steroid administration.
(4) Patients requiring use of topical drugs (e.g., ointment, suppository) during the study period.
(5) Patients with history of hypersensitivity to the ingredient of celecoxib, sulfonamide, or ketoprofen.
(6) Patients with (history of) aspirin asthma (asthma attacks induced by NSAIDs, analgesics, etc.).
(7) Patients with history of hypersensitivity to products containing tiaprofenic acid, suprofen, fenofibrate, oxybenzone, and octocrylene.
(8) Patients with history of photosensitivity.
(9) Patients with peptic ulcers.
(10) Patients with severe hepatic disorders.
(11) Patients with severe renal disorders.
(12) Patients with severe cardiac dysfunctions.
(13) Perioperative patients undergoing coronary artery bypass reconstruction.
(14) Women at the end of pregnancy.
(15) Other patients considered unsuited for the study by their doctors.

Target sample size

72


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kota Watanabe

Organization

Sapporo Medical University School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code


Address

291 S1W17, Chuo-ku, Sapporo, 060-8556, Japan

TEL

011-611-2111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kota Watanabe

Organization

Sapporo Medical University School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code


Address


TEL

011-611-2111

Homepage URL


Email



Sponsor or person

Institute

Sapporo Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 11 Month 01 Day

Date of IRB

2011 Year 10 Month 20 Day

Anticipated trial start date

2012 Year 02 Month 01 Day

Last follow-up date

2013 Year 02 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 02 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 04 Month 10 Day

Last modified on

2022 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008612


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name